Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg (PRNC)
Multicentre Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg in Patients With Chronic Inflammatory Demyelinating Polyneuropathy on a One Year Follow up
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Listed as NCT01349270, this PHASE3 trial focuses on Demyelinating Polyneuropathy and remains completed. Sponsored by Centre Hospitalier Universitaire de Saint Etienne, it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Saint Etienne
- Laboratoire français de Fractionnement et de Biotechnologies
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Clermont-Ferrand, France , Dijon, France , Grenoble, France , Lyon, France , Marseille, France , Nancy, France , Nantes, France , Nice, France , Saint-Etienne, France , Strasbourg, France and 1 more location